Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher C Rowe

Showing results (221-230 of 365) with videos related to

Pageof 37
Sort By:
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|April 5, 2013
Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS)Yen Ying Lim, Judith Jaeger, Karra Harrington, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2012
Research and standardization in Alzheimer's trials: reaching international consensusMaria C Carrillo, Christopher C Rowe, Cassandra Szoeke, et al.
Journal of Alzheimer'S Disease : JAD|November 20, 2012
Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease?Yen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
The Centiloid Project: standardizing quantitative amyloid plaque estimation by PETWilliam E Klunk, Robert A Koeppe, Julie C Price, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 18, 2021
The heritability of amyloid burden in older adults: the Older Australian Twins StudyRebecca Koncz, Anbupalam Thalamuthu, Wei Wen, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 22, 2018
Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort StudyRobert H Pietrzak, Simon M Laws, Yen Ying Lim, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL StudySamantha C Burnham, Nandini Raghavan, William Wilson, et al.
Neuroimage|September 16, 2008
Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy agingJurgen Fripp, Pierrick Bourgeat, Oscar Acosta, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Neurology|April 1, 2016
Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer diseaseYen Ying Lim, Simon M Laws, Victor L Villemagne, et al.
Pageof 37

Showing results (221-230 of 365) with videos related to

Sort By:
Pageof 37
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|April 5, 2013
Three-month stability of the CogState brief battery in healthy older adults, mild cognitive impairment, and Alzheimer's disease: results from the Australian Imaging, Biomarkers, and Lifestyle-rate of change substudy (AIBL-ROCS)Yen Ying Lim, Judith Jaeger, Karra Harrington, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2012
Research and standardization in Alzheimer's trials: reaching international consensusMaria C Carrillo, Christopher C Rowe, Cassandra Szoeke, et al.
Journal of Alzheimer'S Disease : JAD|November 20, 2012
Cognitive decline in adults with amnestic mild cognitive impairment and high amyloid-β: prodromal Alzheimer's disease?Yen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 3, 2014
The Centiloid Project: standardizing quantitative amyloid plaque estimation by PETWilliam E Klunk, Robert A Koeppe, Julie C Price, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 18, 2021
The heritability of amyloid burden in older adults: the Older Australian Twins StudyRebecca Koncz, Anbupalam Thalamuthu, Wei Wen, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging|March 22, 2018
Plasma Cortisol, Brain Amyloid-β, and Cognitive Decline in Preclinical Alzheimer's Disease: A 6-Year Prospective Cohort StudyRobert H Pietrzak, Simon M Laws, Yen Ying Lim, et al.
Journal of Alzheimer'S Disease : JAD|September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL StudySamantha C Burnham, Nandini Raghavan, William Wilson, et al.
Neuroimage|September 16, 2008
Appearance modeling of 11C PiB PET images: characterizing amyloid deposition in Alzheimer's disease, mild cognitive impairment and healthy agingJurgen Fripp, Pierrick Bourgeat, Oscar Acosta, et al.
Journal of Alzheimer'S Disease : JAD|December 17, 2013
Plasma amyloid-β levels are significantly associated with a transition toward Alzheimer's disease as measured by cognitive decline and change in neocortical amyloid burdenAlan Rembach, Andrew D Watt, William J Wilson, et al.
Neurology|April 1, 2016
Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer diseaseYen Ying Lim, Simon M Laws, Victor L Villemagne, et al.
Pageof 37